145 related articles for article (PubMed ID: 31105295)
1. Urothelial carcinoma in children, case report with review of literature.
Arshad Z; Zaidi SZ
J Pak Med Assoc; 2019 May; 69(5):720-721. PubMed ID: 31105295
[TBL] [Abstract][Full Text] [Related]
2. Intravesical therapy for superficial bladder cancer: slow but steady progress.
Lamm DL
J Clin Oncol; 2003 Dec; 21(23):4259-60. PubMed ID: 14581444
[No Abstract] [Full Text] [Related]
3. Primary amyloidosis with high grade transitional cell carcinoma of bladder: a rare case report.
Gupta P; Hanamshetti S; Kulkarni JN
J Cancer Res Ther; 2012; 8(2):297-9. PubMed ID: 22842380
[TBL] [Abstract][Full Text] [Related]
4. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
5. High-grade transitional cell carcinoma of the pediatric bladder.
Korrect GS; Minevich EA; Sivan B
J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic adenoma in a patient with transitional cell carcinoma of the bladder receiving intravesical bacillus Calmette-Guérin.
Oyama N; Tanase K; Akino H; Mori H; Kanamaru H; Okada K
Int J Urol; 1998 Mar; 5(2):185-7. PubMed ID: 9559850
[TBL] [Abstract][Full Text] [Related]
7. Urothelial carcinoma with villoglandular differentiation (UCVGD) with small cell neuroendocrine carcinoma of urinary bladder.
Jha S; Mitra S; Adhya AK; Nayak P
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30661049
[TBL] [Abstract][Full Text] [Related]
8. Bladder urothelial cell carcinoma as a rare cause of haematuria in children: Our experience and review of current literature.
ElSharnoby O; Fraser N; Williams A; Scriven S; Shenoy M
J Pediatr Surg; 2022 Jul; 57(7):1409-1413. PubMed ID: 34563358
[TBL] [Abstract][Full Text] [Related]
9. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
Onishi T; Sekito S; Shibahara T; Uchida K; Sasaki T
Scand J Urol; 2018; 52(5-6):385-388. PubMed ID: 30628540
[TBL] [Abstract][Full Text] [Related]
10. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.
Hausladen DA; Wheeler MA; Altieri DC; Colberg JW; Weiss RM
J Urol; 2003 Jul; 170(1):230-4. PubMed ID: 12796695
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy.
Draga RO; Grimbergen MC; Kok ET; Jonges TN; van Swol CF; Bosch JL
Eur Urol; 2010 Apr; 57(4):655-60. PubMed ID: 19819064
[TBL] [Abstract][Full Text] [Related]
13. Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897).
Van der Meijden AP; Hall RR; Macaluso MP; Pawinsky A; Sylvester R; Van Glabbeke M
Eur Urol; 1996; 29(2):199-203. PubMed ID: 8647147
[TBL] [Abstract][Full Text] [Related]
14. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.
Colombo R; Da Pozzo LF; Salonia A; Rigatti P; Leib Z; Baniel J; Caldarera E; Pavone-Macaluso M
J Clin Oncol; 2003 Dec; 21(23):4270-6. PubMed ID: 14581436
[TBL] [Abstract][Full Text] [Related]
15. [Urothelial tumors in children].
Grapin-Dagorno C; Peycelon M; Philippe-Chomette P; Berrebi D; El Ghoneimi A; Orbach D
Bull Cancer; 2017 Feb; 104(2):195-201. PubMed ID: 28034440
[TBL] [Abstract][Full Text] [Related]
16. Sarcomatoid urothelial carcinoma with disseminated metastases: an aggressive and rare cancer.
Kheiri B; Kanzy A; Krznarich T; Bachuwa G
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28928259
[No Abstract] [Full Text] [Related]
17. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
18. Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study.
Rath-Wolfson L; Moskovitz B; Dekel Y; Kugel V; Koren R
Int J Exp Pathol; 2003 Jun; 84(3):145-52. PubMed ID: 12974944
[TBL] [Abstract][Full Text] [Related]
19. Case Report of a Rare Presentation of Urothelial Carcinoma With Gastric Metastasis.
Wymer KM; Antic T; O'Donnell PH
Clin Genitourin Cancer; 2016 Feb; 14(1):e111-4. PubMed ID: 26456403
[No Abstract] [Full Text] [Related]
20. Long-term follow-up of transitional cell carcinoma of the bladder in childhood.
Bujons A; Caffaratti J; Garat JM; Villavicencio H
J Pediatr Urol; 2014 Feb; 10(1):167-70. PubMed ID: 24035638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
